Corecam Pte Ltd’s Pfizer PFE Stock Holding History

Corecam Pte Ltd’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.6M	Buy	337,830 +15,200	+5%	+$404K	4.02%	6
2026 Q2	$7.77M	Buy	322,630 +26,700	+9%	+$698K	2.94%	12
2026 Q1	$8.31M	Buy	295,930 +6,300	+2%	+$168K	3.6%	10
2025 Q4	$7.21M	Buy	289,630 +7,900	+3%	+$199K	3.75%	10
2025 Q3	$7.18M	Buy	281,730 +10,530	+4%	+$260K	3.75%	9
2025 Q2	$6.57M	Sell	271,200 -6,700	-2%	-$156K	3.68%	12
2025 Q1	$7.04M	Buy	277,900 +1,300	+0.5%	+$34K	3.82%	10
2024 Q4	$7.34M	Buy	276,600 +32,700	+13%	+$887K	3.97%	9
2024 Q3	$7.06M	Buy	243,900 +59,600	+32%	+$1.74M	4.6%	8
2024 Q2	$5.16M	Buy	184,300 +44,700	+32%	+$1.23M	3.84%	12
2024 Q1	$3.87M	Buy	139,600 +53,700	+63%	+$1.49M	3.56%	14
2023 Q4	$2.47M	Buy	+85,900	New	+$2.6M	2.66%	12

Other funds holding PFE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Corecam Pte Ltd's PFE Position: Q3 2026 in Review

Corecam Pte Ltd increased its Pfizer (PFE) stake by 4.7% in Q3 2026, buying an estimated $404K and bringing the position to 337,830 shares worth $9.6M. The position accounts for 4.02% of the portfolio, ranked #6.

Corecam Pte Ltd first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Corecam Pte Ltd held 337,830 shares of Pfizer worth $9.6M as of Q3 2026.
Corecam Pte Ltd bought 15,200 Pfizer shares in Q3 2026, an estimated $404K.
Pfizer made up 4.02% of Corecam Pte Ltd's portfolio in Q3 2026, its #6 holding.
Corecam Pte Ltd first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Corecam Pte Ltd's 13F filing for Q3 2026, filed 23 Oct 2026.